LDOS.N
Latest Trade
99.55USDChange
-1.01(-1.00%)Volume
273,247Today's Range
-
100.7552 Week Range
-
113.65As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 100.56 |
|---|---|
Open | 100.20 |
Volume | 273,247 |
3M AVG Volume | 19.69 |
Today's High | 100.75 |
Today's Low | 99.46 |
52 Week High | 113.65 |
52 Week Low | 79.18 |
Shares Out (MIL) | 141.35 |
Market Cap (MIL) | 14,213.78 |
Forward P/E | 15.78 |
Dividend (Yield %) | 1.35 |
Leidos Holdings Inc Says CEO's FY 2020 Total Compensation Was $12.3 Mln
DTRA Awards Leidos Project To Conduct Clinical Trials For Covid-19 Therapeutics
Leidos Holdings Inc Reports Fourth Quarter And Fiscal Year 2020 Results
Leidos Holdings, Inc. (Leidos) is a holding company. The Company's subsidiary and principal operating company is Leidos, Inc. Leidos is a science, engineering and information technology (IT) company that provides services and solutions in the defense, intelligence, homeland security, civil and health markets, both domestically and internationally. It operates through three segments: Defense Solutions, Civil and Health. Defense Solutions segment provides technologically advanced services, solutions and products to a broad customer base. Civil business is focused on modernizing infrastructure, systems and security for government and commercial customers both domestically and internationally. Health business focuses on providing solutions to federal and commercial customers that are responsible for the health and well-being of people worldwide, including service members and veterans.
Industry
Computer Services
Executive Leadership
Roger A. Krone
Chairman of the Board, Chief Executive Officer
James C. Reagan
Chief Financial Officer, Executive Vice President
Gerald A. Fasano
Group President - Defense Group
David Arnold King
Group President - Dynetics
James Robert Moos
Group President - Civil Group
Price To Earnings (TTM) | 23.06 |
|---|---|
Price To Sales (TTM) | 1.16 |
Price To Book (MRQ) | 3.70 |
Price To Cash Flow (TTM) | 15.60 |
Total Debt To Equity (MRQ) | 122.84 |
LT Debt To Equity (MRQ) | 120.25 |
Return on Investment (TTM) | 7.57 |
Return on Equity (TTM) | 5.75 |
* ORGENESIS AND LEIDOS COLLABORATE ON POTENTIAL TREATMENT FOR COVID-19 Source text for Eikon: Further company coverage:
* TARGOVAX ENTERS COLLABORATION WITH LEIDOS TO ADD CHECKPOINT INHIBITOR FUNCTIONALITY TO ONCOS VIRUSES
An appeals court on Thursday dealt a setback to Microsoft in a patent infringement case brought by the defense contractor Leidos, saying an administrative court's refusal to review the asserted patents was not appealable.
Leidos Holdings Inc has been awarded a $445 million contract for U.S. Air Force information technology services, the Pentagon said on Tuesday.
* LEIDOS SELECTED TO PROVIDE CONTINUED MISSION-CRITICAL IT SUPPORT FOR THE U.S. ARMY CORPS OF ENGINEERS
* LEIDOS - AWARDED CONTRACT BY U.S. ARMY CONTRACTING COMMAND - ORLANDO
* NATIONAL GEOSPATIAL-INTELLIGENCE AGENCY AWARDS LEIDOS $250 MILLION TASK ORDERS
* LEIDOS HOLDINGS, INC. REPORTS FIRST QUARTER FISCAL YEAR 2018 RESULTS
* LEIDOS AWARDED GEO 7 TASK ORDER TO ENHANCE U.S. AIR TRAFFIC SYSTEM
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.